Quality of anticoagulation with warfarin in rural Chhattisgarh, India

被引:6
作者
Chebrolu, Puja [1 ]
Patil, Sushil [4 ]
Laux, Timothy S. [3 ]
Al-Hammadi, Noor [2 ]
Jain, Yogesh [4 ]
Gage, Brian [1 ]
机构
[1] Washington Univ, Dept Med, St Louis, MO USA
[2] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[3] Columbia Univ, Med Ctr, Dept Hosp Med, New York, NY USA
[4] Jan Swasthya Sahyog, Ganiyari, Chhattisgarh, India
关键词
INTERNATIONAL NORMALIZED RATIO; ATRIAL-FIBRILLATION; ORAL ANTICOAGULANT; STROKE; THERAPY; METAANALYSIS; DABIGATRAN; INTENSITY; EFFICACY; OUTCOMES;
D O I
10.4103/ijmr.IJMR_1201_18
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: In most of rural India, warfarin is the only oral anticoagulant available. Among patients taking warfarin, there is a strong association between poor control of the international normalized ratio (INR) and adverse events. This study was aimed to quantify INR control in a secondary healthcare system in rural Chhattisgarh, India. Methods: The INR data were retrospectively obtained from all patients taking warfarin during 2014-2016 at a secondary healthcare system in rural Chhattisgarh, India. Patients attending the clinic had their INR checked at the hospital laboratory and their warfarin dose adjusted by a physician on the same day. The time in therapeutic range (TTR) was calculated for patients who had at least two INR visits. Results: The 249 patients had 2839 INR visits. Their median age was 46 yr, and the median body mass index was 17.7 kg/m[2]. They lived a median distance of 78 km (2-3 h of travel) from the hospital. The median INR was 1.7 for a target INR of 2.0-3.0 (n=221) and 2.1 for a target of 2.5-3.5 (n=28). The median TTR was 13.0 per cent, and INR was subtherapeutic 66.0 per cent of the time. Distance from the hospital was not correlated with TTR. Interpretation & conclusions: INR values were subtherapeutic two-thirds of the time, and TTR values were poor regardless of distance from the health centre. Future studies should be done to identify interventions to improve INR control.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [41] Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48
    Giugliano, Robert P.
    Ruff, Christian T.
    Rost, Natalia S.
    Silverman, Scott
    Wiviott, Stephen D.
    Lowe, Cheryl
    Deenadayalu, Naveen
    Murphy, Sabina A.
    Grip, Laura T.
    Betcher, Joshua M.
    Duggal, Anil
    Dave, Jay
    Shi, Minggao
    Mercuri, Michele
    Antman, Elliott M.
    Braunwald, Eugene
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    Rosell, M.
    Cuneo, C.
    Bocanera, M.
    D'Amico, A.
    STROKE, 2014, 45 (08) : 2372 - 2378
  • [42] The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled Trial
    Garrison, Scott R.
    Green, Lee
    Kolber, Michael R.
    Korownyk, Christina S.
    Olivier, Nicole M.
    Heran, Balraj S.
    Flesher, Mary E.
    Allan, G. Michael
    ANNALS OF FAMILY MEDICINE, 2020, 18 (01) : 42 - 49
  • [43] Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
    Maddox, William
    Kay, G. Neal
    Yamada, Takumi
    Osorio, Jose
    Doppalapudi, Harish
    Plumb, Vance J.
    Gunter, Alicia
    Mcelderry, H. Thomas
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (08) : 861 - 865
  • [44] The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting
    Urbonas, Gediminas
    Valius, Leonas
    Sakalyte, Gintare
    Petniunas, Kestutis
    Petniuniene, Inesa
    MEDICINA-LITHUANIA, 2019, 55 (01):
  • [45] Anticoagulation control of warfarin in anticoagulation medication therapy adherence clinics
    Mazlan-Kepli, Wardati
    Mohamed, Sahimi
    Nik-Ismail, Nik-Azlean
    R-Nagarajah, Jivanraj
    Clinical Pharm Working Comm Cardiology Subspecialty
    Pharmaceutical Serv Programme
    Minist Hlth Malaysia
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2025,
  • [46] The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients
    Poli, Daniela
    Antonucci, Emilia
    Marcucci, Rossella
    Mannini, Lucia
    Falciani, Michela
    Abbate, Rosanna
    Gensini, Gian Franco
    Prisco, Domenico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (01) : 109 - 113
  • [47] Modeling patients' time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants
    Leminen, Aapeli
    Pyykonen, Mikko
    Tynkkynen, Juho
    Tykkylainen, Markku
    Laatikainen, Tiina
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (01)
  • [48] Health literacy and warfarin therapy at two anticoagulation clinics in Brazil
    Parreiras Martins, Maria Auxiliadora
    Costa, Josiane Moreira
    de Melo Mambrini, Juliana Vaz
    Pinho Ribeiro, Antonio Luiz
    Benjamin, Emelia J.
    Caldeira Brant, Luisa Campos
    Paasche-Orlow, Michael K.
    Magnani, Jared W.
    HEART, 2017, 103 (14) : 1089 - 1095
  • [49] Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control
    Ho, Chi-Wai
    Ho, Mei-Han
    Chan, Pak-Hei
    Hai, Jo-Jo
    Cheung, Emmanuel
    Yeung, Chun-Yip
    Lau, Kui-Kai
    Chan, Koon-Ho
    Lau, Chu-Pak
    Lip, Gregory Y. H.
    Leung, Gilberto Ka-Kit
    Tse, Hung-Fat
    Siu, Chung-Wah
    STROKE, 2015, 46 (01) : 23 - 30
  • [50] Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation
    Bryk, Agata Hanna
    Plens, Krzysztof
    Undas, Anetta
    CARDIOLOGY JOURNAL, 2017, 24 (05) : 477 - 483